People | August 02, 2022
Sam Samad will be departing Illumina on July 8, 2022, after serving as CFO for more than five years.
The $44 million facility is part of Thermo Fisher's $650 million multi-year investment, announced last year, to help ensure flexible, scalable and reliable bioprocessing production capacity exists for critical materials used in developing new and existing biologics and vaccines, including for COVID-19
Breakthrough formulation helps reduce the risk of exposure using a non-hazardous formulation and leakproof format during transport and processing
New instrument helps maximize lab productivity and extends FTIR to large, heavy samples
The US $ 192.5 mn US government contract will help fund the centre of excellence to boost the domestic supply of critically needed laboratory plastics
Thermo Fisher Scientific expands diagnostics portfolio to support full qPCR assay development and testing workflow
The Thermo Scientific Orbitrap Exploris MX enables customer success by combining high-quality data with operational simplicity
Two leaders in science combine complementary best-in-class technologies for biologics manufacturing customers
The Amplitude Solution gives laboratories the ability to scale Covid-19 PCR testing and process up to 8,000 samples a day
Subscribe To Our Newsletter & Stay Updated
